285 related articles for article (PubMed ID: 21568845)
1. Mutator effects and mutation signatures of editing deaminases produced in bacteria and yeast.
Lada AG; Krick CF; Kozmin SG; Mayorov VI; Karpova TS; Rogozin IB; Pavlov YI
Biochemistry (Mosc); 2011 Jan; 76(1):131-46. PubMed ID: 21568845
[TBL] [Abstract][Full Text] [Related]
2. APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis.
Rogozin IB; Basu MK; Jordan IK; Pavlov YI; Koonin EV
Cell Cycle; 2005 Sep; 4(9):1281-5. PubMed ID: 16082223
[TBL] [Abstract][Full Text] [Related]
3. [Vertebrate immunity: mutator proteins and their evolution].
Lada AG; Iyer LM; Rogozin IB; Aravind L; Pavlov IuI
Genetika; 2007 Oct; 43(10):1311-27. PubMed ID: 18069336
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
Conticello SG; Thomas CJ; Petersen-Mahrt SK; Neuberger MS
Mol Biol Evol; 2005 Feb; 22(2):367-77. PubMed ID: 15496550
[TBL] [Abstract][Full Text] [Related]
5. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases.
Nakamuta M; Oka K; Krushkal J; Kobayashi K; Yamamoto M; Li WH; Chan L
J Biol Chem; 1995 Jun; 270(22):13042-56. PubMed ID: 7768898
[TBL] [Abstract][Full Text] [Related]
6. Genetic and in vitro assays of DNA deamination.
Coker HA; Morgan HD; Petersen-Mahrt SK
Methods Enzymol; 2006; 408():156-70. PubMed ID: 16793368
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
Beale RC; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; Neuberger MS
J Mol Biol; 2004 Mar; 337(3):585-96. PubMed ID: 15019779
[TBL] [Abstract][Full Text] [Related]
8. Identification of the yeast cytidine deaminase CDD1 as an orphan C-->U RNA editase.
Dance GS; Beemiller P; Yang Y; Mater DV; Mian IS; Smith HC
Nucleic Acids Res; 2001 Apr; 29(8):1772-80. PubMed ID: 11292850
[TBL] [Abstract][Full Text] [Related]
9. Mouse APOBEC1 cytidine deaminase can induce somatic mutations in chromosomal DNA.
Caval V; Jiao W; Berry N; Khalfi P; Pitré E; Thiers V; Vartanian JP; Wain-Hobson S; Suspène R
BMC Genomics; 2019 Nov; 20(1):858. PubMed ID: 31726973
[TBL] [Abstract][Full Text] [Related]
10. Statistical modelling and phylogenetic analysis of a deaminase domain.
Mian IS; Moser MJ; Holley WR; Chatterjee A
J Comput Biol; 1998; 5(1):57-72. PubMed ID: 9541871
[TBL] [Abstract][Full Text] [Related]
11. Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function.
Severi F; Chicca A; Conticello SG
Mol Biol Evol; 2011 Mar; 28(3):1125-9. PubMed ID: 21172829
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Vif protein blocks the cytidine deaminase activity of B-cell specific AID in E. coli by a similar mechanism of action.
Santa-Marta M; Aires da Silva F; Fonseca AM; Rato S; Goncalves J
Mol Immunol; 2007 Jan; 44(4):583-90. PubMed ID: 16580072
[TBL] [Abstract][Full Text] [Related]
13. Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo.
Petit V; Guétard D; Renard M; Keriel A; Sitbon M; Wain-Hobson S; Vartanian JP
J Mol Biol; 2009 Jan; 385(1):65-78. PubMed ID: 18983852
[TBL] [Abstract][Full Text] [Related]
14. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.
Sawyer SL; Emerman M; Malik HS
PLoS Biol; 2004 Sep; 2(9):E275. PubMed ID: 15269786
[TBL] [Abstract][Full Text] [Related]
15. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
[TBL] [Abstract][Full Text] [Related]
16. DNA deamination in immunity: AID in the context of its APOBEC relatives.
Conticello SG; Langlois MA; Yang Z; Neuberger MS
Adv Immunol; 2007; 94():37-73. PubMed ID: 17560271
[TBL] [Abstract][Full Text] [Related]
17. APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.
Holmes RK; Koning FA; Bishop KN; Malim MH
J Biol Chem; 2007 Jan; 282(4):2587-95. PubMed ID: 17121840
[TBL] [Abstract][Full Text] [Related]
18. Diverse functions for DNA and RNA editing in the immune system.
Hamilton CE; Papavasiliou FN; Rosenberg BR
RNA Biol; 2010; 7(2):220-8. PubMed ID: 20220309
[TBL] [Abstract][Full Text] [Related]
19. An overview of cytidine deaminases.
Navaratnam N; Sarwar R
Int J Hematol; 2006 Apr; 83(3):195-200. PubMed ID: 16720547
[TBL] [Abstract][Full Text] [Related]
20. APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
Franca R; Spadari S; Maga G
Med Sci Monit; 2006 May; 12(5):RA92-8. PubMed ID: 16641889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
